Uterine Fibroids Clinical Trials

A listing of Uterine Fibroids medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 4630 clinical trials
Featured trial
Alzheimer's Disease Family Based Study (AD FBS)

This study is looking for people who have Alzheimer’s or a related dementia, and also have family members who have Alzheimer’s. The study is interested in the genetics of Alzheimer’s risk.

Accepts healthy volunteers
Online studies
dementia
  • 2326 views
  • 31 Jan, 2023
  • 1 location
  • Online study
Featured trial
Parkinson's Progression Markers Initiative Online (PPMI Online)

Parkinson's Progression Markers Initiative Online (PPMI online) is part of the broader Parkinson’s Progression Markers Initiative aimed at better understanding who gets Parkinson’s disease and why. PPMI online is a study collecting participant reported demographic and health information online from people with and without Parkinson’s disease. Once in the study, …

Accepts healthy volunteers
Online studies
  • 168 views
  • 14 Sep, 2022
  • 1 location
  • Online study
Featured trial
BIVV020 in Prevention and Treatment of Antibody-mediated Rejection (AMR)  

Primary Objectives:
<ul>
  • Cohort A: To evaluate the efficacy of BIVV020 in prevention of AMR
  • Cohort B: To evaluate the efficacy of BIVV020 in treatment of active AMR
    • kidney transplant
    tacrolimus
    corticosteroids
    ivig
    • 16 views
    • 02 Feb, 2023
    • 20 locations
    Featured trial
    Dupilumab in Allergic Fungal Rhinosinusitis (AFRS) (LIBERTY-AFRS-AI)  

    Primary Objective:

    <ul>
  • To evaluate the ability of dupilumab to reduce the need for rescue therapy with systemic corticosteroids (SCS) or surgery of AFRS in patients with AFRS who

    • 89 views
    • 27 Jan, 2023
    • 41 locations
    Featured trial
    Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus Erythematosus (CLEan)

    Primary Objective:
    <ul>
  • Assess the efficacy of SAR443122 in cutaneous lupus erythematosus (CLE)
    • ul>
    Secondary Objectives:
    <ul>
  • Assess the effect of SAR443122

    • 25 views
    • 25 Jan, 2023
    • 5 locations
    Featured trial
    Efficacy and Safety of SAR441344 in the Treatment of Systemic Lupus Erythematosus (APATURA)

    the treatment of participants aged 18 to 70 years with active Systemic Lupus Erythematosus (SLE). Study details include:

    <ul>
  • Study duration: 36 weeks
  • Treatment duration: 24 weeks

    lupus
    arthritis
    antinuclear antibody
    rash
    • 10 views
    • 25 Jan, 2023
    • 6 locations
    Featured trial
    A Study of TAK-341 in Treatment of Multiple System Atrophy

    The main aim is to see how TAK-341 works after 52 weeks in participants with multiple system atrophy as measured by the Unified Multiple System Atrophy Rating Scale Part I (UMSARS). The study will enroll approximately 138 patients. Participants will receive a total of 13 intravenous infusions every 4 weeks …

    • 20 views
    • 14 Dec, 2022
    • 1 location
    Featured trial
    Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD) (AERIFY-2)  

    Primary Objective:
    Primary population (former smokers cohort):
    <ul>
  • Evaluate the efficacy of itepekimab compared with placebo on the annualized rate of acute moderate-or

    • 758 views
    • 02 Feb, 2023
    • 90 locations
    Featured trial
    Proof of Concept Study of Rilzabrutinib in Adult Participants With Moderate-to-severe Asthma

    therapy of ICS/LABA will be withdrawn during the 12week randomized treatment period and resumed at the end of the IMP treatment period, as outlined below:

    <ul>
  • Screening period (4 weeks)
    • 5 views
    • 06 Jan, 2023
    • 23 locations
    Featured trial
    EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients (EVEREST)

    Primary Objective

    -To evaluate the efficacy of dupilumab compared to omalizumab in reducing the polyp size and improving sense of smell

    Secondary Objectives

    <ul>
  • To

    • 42 views
    • 26 Jan, 2023
    • 69 locations